Most of vitamin supplement studies flawed: Study

Image
ANI Washington
Last Updated : Dec 31 2013 | 10:10 AM IST

A new research has suggested that most clinical trials of vitamin supplements, including some that concluded they are of no value or even harmful, have a flawed methodology, which makes them largely useless in determining the real value of these micronutrients.

Many projects have tried to study nutrients that are naturally available in the human diet the same way they would a powerful prescription drug.

Balz Frei, professor and director of the Linus Pauling Institute at Oregon State University, said that this leads to conclusions that have little scientific meaning, even less accuracy and often defy a wealth of other evidence.

Lead author Alexander Michels, an LPI research associate, said that in cell culture experiments that are commonly done in a high oxygen environment, vitamin C is unstable and can actually appear harmful.

He said that almost every animal in the world, unlike humans, is able to synthesize its own vitamin C and doesn't need to obtain it in the diet, which makes it difficult to do any lab animal tests with this vitamin that are relevant to humans.

The new review has been published in the journal Nutrients.

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

First Published: Dec 31 2013 | 10:06 AM IST

Next Story